Inhibrx Biosciences  logo

Inhibrx Biosciences Share Price (NASDAQ: INBX)

$23.75

0.42

(1.8%)

Live

Last updated on

Check the interactive Inhibrx Biosciences Stock chart to analyse performance

Inhibrx Biosciences stock performance

as on August 19, 2025 at 12:36 AM IST

  • Today's Low:$23.75
    Today's High:$23.97

    Day's Volatility :0.92%

  • 52 Weeks Low:$10.81
    52 Weeks High:$25.29

    52 Weeks Volatility :57.28%

Inhibrx Biosciences Stock Returns

PeriodInhibrx Biosciences, Inc. Sector (Health Care)Index (Russel 2000)
3 Months
87.09%
2.3%
0.0%
6 Months
78.5%
-5.8%
0.0%
1 Year
80.15%
-10.9%
0.0%
3 Years
21.19%
2.8%
-11.6%

Inhibrx Biosciences, Inc. Key Stats

Check Inhibrx Biosciences key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$23.33
Open
$23.58
Today's High
$23.97
Today's Low
$23.88
Market Capitalization
$220.2M
Today's Volume
$97.8K
52 Week High
$25.29
52 Week Low
$10.805
Revenue TTM
$200.0K
EBITDA
$-229.9M
Earnings Per Share (EPS)
$119.02
PE Ratio
0.13
Profit Margin
861485.5%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
41.18%

Stock Returns calculator for Inhibrx Biosciences Stock including INR - Dollar returns

The Inhibrx Biosciences stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Inhibrx Biosciences investment value today

Current value as on today

₹1,87,471

Returns

₹87,471

(+87.47%)

Returns from Inhibrx Biosciences Stock

₹83,398 (+83.4%)

Dollar Returns*

₹4,073 (+4.07%)

Indian investors sentiment towards Inhibrx Biosciences Stock

-11%

Period: Jul 18, 2025 to Aug 17, 2025. Change in 30 Days versus previous period

Search interest for Inhibrx Biosciences Stock from India on INDmoney has decreased by -11% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Inhibrx Biosciences, Inc.

  • Name

    Holdings %

Analyst Recommendation on Inhibrx Biosciences Stock

Rating
Trend

Hold

    0%Buy

    62%Hold

    37%Sell

Based on 8 Wall street analysts offering stock ratings for Inhibrx Biosciences (by analysts ranked 0 to 5 stars)

Inhibrx Biosciences Share Price Target

What analysts predicted

Downside of 49.47%

Target:

$12.00

Current:

$23.75

Inhibrx Biosciences share price target is $12.00, a slight Downside of 49.47% compared to current price of $23.75 as per analysts' prediction.

Inhibrx Biosciences Stock Insights

  • Price Movement

    In the last 3 months, INBX stock has moved up by 89.2%
  • Increasing Revenue

    Revenue is up for the last 2 quarters, 100.0K → 1.3M (in $), with an average increase of 92.3% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 3 quarters, -47.86M → -28.65M (in $), with an average increase of 30.8% per quarter
  • INBX vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 100.9% return, outperforming this stock by 84.4%

Inhibrx Biosciences Technicals Summary

Sell

Neutral

Buy

Inhibrx Biosciences is currently in a neutral trading position according to technical analysis indicators.

Inhibrx Biosciences, Inc. Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Inhibrx Biosciences, Inc.  logo
5.47%
78.5%
80.15%
21.19%
13.09%
Regeneron Pharmaceuticals, Inc. logo
6.39%
-14.65%
-51.51%
-6.14%
-7.82%
Beone Medicines Ltd logo
10.08%
34.96%
66.94%
83.8%
36.85%
Vertex Pharmaceuticals Incorporated logo
-14.33%
-15.0%
-19.52%
31.35%
45.44%
Alnylam Pharmaceuticals, Inc. logo
40.06%
79.56%
63.55%
107.86%
227.15%

About Inhibrx Biosciences, Inc.

Inhibrx Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of biologic therapeutics for people with life-threatening conditions. Its therapeutic candidates include INBRX-109, a tetravalent therapeutic candidate targeting death-receptor 5 to treat unresectable or metastatic conventional chondrosarcoma; and INBRX-106, a hexavalent sdAb-based therapeutic candidate targeting OX4 for the treatment of metastatic solid tumor, non-small cell lung cancer, melanoma, head and neck squamous cell carcinoma, gastric or gastroesophageal junction adenocarcinoma, renal cell carcinoma, and urothelial cell carcinoma. Inhibrx Biosciences, Inc. was incorporated in 2024 and is based in La Jolla, California.
Organization
Inhibrx Biosciences
Employees
156
CEO
Mr. Mark Paul Lappe
Industry
Health Technology

Key Management of Inhibrx Biosciences, Inc.

NameTitle
Mr. Mark Paul Lappe
Founder, CEO & Chairman
Mr. David J. Matly M.B.A.
President
Ms. Bonne Adams M.B.A.
Vice President of Operations
Dr. Ashraf Amanullah Ph.D.
Executive VP & Chief Technical Operations Officer
Dr. Carlos Bais Ph.D.
EVP & Chief Scientific Officer
Ms. Leah Pollema J.D.
VP, General Counsel & Corporate Secretary
Dr. Josep Garcia Ph.D.
Executive VP & Chief Clinical Development Officer

Important FAQs about investing in INBX Stock from India :

What is Inhibrx Biosciences share price today?

Inhibrx Biosciences share price today is $23.75 as on . Inhibrx Biosciences share today touched a day high of $23.97 and a low of $23.75.

What is the 52 week high and 52 week low for Inhibrx Biosciences share?

Inhibrx Biosciences share touched a 52 week high of $25.29 and a 52 week low of $10.81. Inhibrx Biosciences stock price today, is trending at $23.75, lower by 6.09% versus the 52 week high.

How to invest in Inhibrx Biosciences Stock (INBX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Inhibrx Biosciences on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Inhibrx Biosciences Shares that will get you 0.0632 shares as per Inhibrx Biosciences share price of $23.75 per share as on August 19, 2025 at 12:36 AM IST.

What is the minimum amount required to buy Inhibrx Biosciences Stock (INBX) from India?

Indian investors can start investing in Inhibrx Biosciences (INBX) shares with as little as ₹87.3775 or $1 (as of August 18, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹873.77 in Inhibrx Biosciences stock (as per the Rupee-Dollar exchange rate as on August 18, 2025). Based on Inhibrx Biosciences share’s latest price of $23.75 as on August 19, 2025 at 12:36 AM IST, you will get 0.4211 shares of Inhibrx Biosciences . Learn more about fractional shares .

What are the returns that Inhibrx Biosciences has given to Indian investors in the last 5 years?

Inhibrx Biosciences stock has given 13.09% share price returns and 16.91% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your US Stock Investments?